Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
Checkpoint Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Checkpoint Therapeutics reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, two executives at Checkpoint Therapeutics received on average a compensation package of $1.4M, a 11% increase compared to previous year.
Average pay of disclosed executives at Checkpoint Therapeutics
James F. Oliviero III, Chief Executive Officer, received $2.3M in total, which increased by 8% compared to 2018. 68% of Oliviero's compensation, or $1.6M, was in stock awards. Oliviero also received $252K in non-equity incentive plan and $480K in salary.
William Garrett Gray, Vice President, Finance and Accounting, received a compensation package of $542K, which increased by 24% compared to previous year. 54% of the compensation package, or $293K, was in stock awards.
Related executives
You may also like
Source: SEC filing on April 24, 2020.